retatrutide triple agonist obesity 🚨 Today, retatrutide, the GIP/GLP-1/glucagon agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent and type 2 diabetes. 📊 Mean body weight change at 80 weeks: ⬇️ Retatrutide Explained: The Triple Agonist

Eur J Pharmacol 667(13):322329 Jelovac N, Sikiric P, Rucman R et al (1998) A novel pentadecapeptide, BPC 157, blocks the stereotypy produced acutely by amphetamine and the development of haloperidol-induced supersensitivity to amphetamine

Zincs role in DNA repair promotes cellular health by preserving the integrity of genetic information and minimizing damage brought on by oxidative stress (155)

But most of these drugs are not approved for human consumption by regulators, because we dont fully understand what theyre doing to our bodies

Are both FDA-approved for obesity

EFSA Panel on Nutrition Novel Foods and Food Allergens